Everence Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Sell
9,029
-1,931
-18% -$41.6K 0.01% 738
2025
Q4
$219K Hold
10,960
0.01% 718
2025
Q3
$200K Hold
10,960
0.01% 772
2025
Q2
$220K Hold
10,960
0.01% 723
2025
Q1
$199K Hold
10,960
0.01% 752
2024
Q4
$190K Sell
10,960
-1,010
-8% -$19.4K 0.01% 792
2024
Q3
$231K Hold
11,970
0.01% 683
2024
Q2
$181 Hold
11,970
0.01% 696
2024
Q1
$182 Hold
11,970
0.01% 729
2023
Q4
$192K Hold
11,970
0.01% 708
2023
Q3
$155 Hold
11,970
0.01% 706
2023
Q2
$161K Hold
11,970
0.01% 681
2023
Q1
$135 Hold
11,970
0.01% 724
2022
Q4
$159 Hold
11,970
0.01% 724
2022
Q3
$139K Hold
11,970
0.01% 694
2022
Q2
$177K Hold
11,970
0.02% 674
2022
Q1
$232K Hold
11,970
0.02% 647
2021
Q4
$206K Hold
11,970
0.02% 721
2021
Q3
$200K Hold
11,970
0.02% 699
2021
Q2
$161K Hold
11,970
0.01% 718
2021
Q1
$143K Hold
11,970
0.01% 706
2020
Q4
$148K Hold
11,970
0.01% 678
2020
Q3
$125K Hold
11,970
0.01% 651
2020
Q2
$167K Hold
11,970
0.02% 602
2020
Q1
$141K Buy
+11,970
New +$158K 0.02% 560

Other funds holding INVA

Everence Capital Management's INVA Position: Q1 2026 in Review

Everence Capital Management reduced its Innoviva (INVA) stake by 18% in Q1 2026, selling an estimated $41.6K and leaving 9,029 shares worth $210K. The position accounts for 0.01% of the portfolio, ranked #738.

Everence Capital Management first reported a position in INVA in Q1 2020 and has held it in 25 quarters since. The position peaked at $232K in Q1 2022. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Everence Capital Management held 9,029 shares of Innoviva worth $210K as of Q1 2026.
  • Everence Capital Management sold 1,931 Innoviva shares in Q1 2026, an estimated $41.6K.
  • Innoviva made up 0.01% of Everence Capital Management's portfolio in Q1 2026, its #738 holding.
  • Everence Capital Management first reported a position in Innoviva in Q1 2020 and has held it in 25 quarters since.
  • Everence Capital Management's Innoviva position peaked at $232K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.